Guys and Saint Thomas NHS Foundation Trust

London, England SE1 9Rt

0 studies enrolling now · 10 studies all time

What they study most

Advanced Malignancies, Carcinoma, Critical Illness, Enteral Feeding Intolerance, Enteral Nutrition, HNSCC, HRAS Gene Mutation, Hepatitis C, Chronic, Indolent Non-Hodgkin's Lymphomas, Lung Cancer, Non-small Cell Lung Cancer, Post-essential Thrombocythemia Myelofibrosis

Studies at this site

• A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) — Stopped early
• A Study of IMR-687 in Subjects With Sickle Cell Disease — Stopped early
• Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy — Completed
• A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM) — Completed
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants — Completed
• TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI) — Stopped early
• TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy — Stopped early
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed